A new drug has shown promising pre-clinical activity against cells from several types of children’s cancers, scientists reveal at the National Cancer Research Institute Conference in Birmingham.
New study findings show that exposure to on-screen smoking in movies has a strong correlation with beginning to smoke or becoming established smokers among young adults 18-25, a critical age group for lifelong smoking behavior.
When an adult suffers a cardiorespiratory arrest the rapid application of an electrical discharge with a defibrillator can avoid sudden death in many cases. Nevertheless, defibrillation also has its impediment or enemy: time. For every minute that passes from the moment of the attack, the possibilities of survival drop by 10%.
Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.
A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.
According to a study conducted at Columbia University’s Mailman School of Public Health among lesbian, gay, and bisexual populations, blacks and Latinos do not have more mental disorders than whites.
Neuroscientists at Vanderbilt University are stepping into the national limelight with the establishment of a Silvio O. Conte Center for Neuroscience Research. The new center, funded by a $10 million grant from the National Institute of Mental Health (NIMH), will support interdisciplinary studies aimed at understanding the gene networks that control serotonin systems in the brain.
The first significant genetic finding in premenstrual dysphoric disorder (PMDD) has now been reported. PMDD is a very severe form of the more commonly known premenstrual syndrome, or PMS. PMDD is heritable, affects 5-8% of women, and is associated with severe emotional and physical problems, such as irritability, marked depressed mood, anger, headaches, weight gain and more, to such an extent that quality of life is seriously impacted.
One of the biggest problems in the current treatment of cancer is that the agents that are efficacious in the destruction of tumorous cells are, at the same time, extremely toxic for the rest of the healthy cells and tissues of the patient. To address the problem the University of the Basque Country (UPV/EHU) is seeking more specific treatments and studying the differences between tumorous cells and healthy ones.
A cadre of private and public entities in the addiction treatment field announced the launch of the National Adopting Changes to Improve Outcomes Now (ACTION) Campaign for the improvement of addiction treatment services. The ACTION Campaign goals are to increase access to addiction treatment for individuals in need and to keep clients engaged in treatment.